Mitochondrial defects, however, are associated with the development of diseases such as type 2 diabetes. Patients who suffer from this disorder are unable to produce enough insulin or use the ...

If successful, TYK2 blockers could change how doctors approach type 1 diabetes. Instead of only managing blood sugar, they might be able to preserve the cells that produce insulin in the first place.

In the ongoing global fight against diabetes, Abaleke Innocent Onyedikachi has emerged as a trailblazer in nutritional biochemistry, pioneering innovative dietary solutions for diabetes management.

Kumar presents the new research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, held March 23–26 in San Antonio. Diabetes and Alzheimer's are ...

The trial of the drug, orforglipron, measured its efficacy and safety in adults with Type 2 diabetes compared to a placebo. It found the pill lowered A1C, a blood level used to diagnose diabetes ...